Covestor’s Sionna Therapeutics SION Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$0 Sell
7
-5
-42% -$115 ﹤0.01% 2942
2026
Q2
$1K Buy
12
+9
+300% +$360 ﹤0.01% 2424
2026
Q1
$0 Buy
+3
New – ﹤0.01% 2885

Other funds holding SION

Covestor's SION Position: Q3 2026 in Review

Covestor reduced its Sionna Therapeutics (SION) stake by 42% in Q3 2026, selling an estimated $115 and leaving 7 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2942.

Covestor first reported a position in SION in Q1 2026 and has held it in 3 quarters since. The position peaked at $1K in Q2 2026. 136 funds tracked by Wall St. Rank hold SION as of Q3 2026.

  • Covestor held 7 shares of Sionna Therapeutics worth $0 as of Q3 2026.
  • Covestor sold 5 Sionna Therapeutics shares in Q3 2026, an estimated $115.
  • Sionna Therapeutics made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2942 holding.
  • Covestor first reported a position in Sionna Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Covestor's Sionna Therapeutics position peaked at $1K in Q2 2026.
  • 136 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.